Fendx Technologies files patent application in U.S.

Dr. Carolyn Myers reports FENDX FILES PROVISIONAL PATENT FOR NOVEL ANTIMICROBIAL NANOPARTICLE LIQUID COATING Fendx Technologies Inc. has filed a provisional patent application with the U.S. Patent and Trademark Office. The application, titled "Antimicrobial Coating for Long-Lasting Pathogen Control on High-Touch Surfaces," assigned application No. 63/936,328, was filed on Aug. 7, 2025, by Dr. Carolyn Myers, Dr. Tohid Didar, Dr. Leyla Soleymani and Dr. Sara Moetakef Imani, with Fendx as the assignee. This filing marks a significant addition to the company's expanding portfolio of hygiene-related technologies. The new application describes a novel nanoparticle liquid coating (formerly described as the spray technology) designed to provide long-lasting protection against a broad spectrum of pathogens found on high-touch surfaces. Engineered for easy application, using, for example, a roller or brush, the coating leverages nanoparticle technology to actively disrupt microbial contamination, offering sustained efficacy in multiple settings. "We are pleased with the progress of our development efforts on this liquid coating technology, which have resulted in the filing of this patent application," said Dr. Myers, chief executive officer of Fendx. "We are now actively assessing scale-up and distribution partnership opportunities to bring this technology to the market. This innovation underscores Fendx's commitment to developing scalable solutions aimed at reducing infection risk." About Fendx Technologies Inc. Fendx is a surface protection company leveraging its proprietary technology to develop product solutions that help reduce the spread of harmful pathogens in everyday environments. The company is advancing its pipeline of products under development, which includes Repelwrap film, a protective surface coating with repelling properties that significantly reduce adhesion and transmission of pathogens on high-touch surfaces; and nanoparticle-infused liquid coating with similar functionality. Additionally, the company is developing specialized catheter coatings, with its first coating being for Foley catheters. The company holds exclusive worldwide licences and intellectual property for its coating technologies. We seek Safe Harbor.